What is the projected market valuation for the US military wearable market in 2035?

The projected market valuation for the US military wearable market in 2035 is $1179.88 Million. Read More

What was the overall market valuation for the US military wearable market in 2024?

The overall market valuation for the US military wearable market in 2024 was $899.04 Million. Read More

What is the expected CAGR for the US military wearable market during the forecast period 2025 - 2035?

The expected CAGR for the US military wearable market during the forecast period 2025 - 2035 is 2.5%. Read More

Which companies are considered key players in the US military wearable market?

Key players in the US military wearable market include Lockheed Martin, Northrop Grumman, Raytheon Technologies, and others. Read More

What are the main technology segments in the US military wearable market?

The main technology segments include Sensors, GPS Devices, Biometric Monitoring Devices, and Augmented Reality. Read More

How much was the market valuation for Biometric Monitoring Devices in 2024?

The market valuation for Biometric Monitoring Devices in 2024 was between $250.0 Million and $300.0 Million. Read More

What types of wearable technology are included in the US military market?

Types of wearable technology include Smart Helmets, Body Armor, Wearable Exoskeletons, and Smart Clothing. Read More

What is the market valuation for Body Armor in 2024?

The market valuation for Body Armor in 2024 was between $300.0 Million and $400.0 Million. Read More

Which end-use segment has the highest projected valuation in 2035?

The Special Forces end-use segment has the highest projected valuation in 2035, estimated at $409.88 Million. Read More

What functionalities are prioritized in the US military wearable market?

Prioritized functionalities include Communication, Health Monitoring, Surveillance, and Navigation. Read More

US Military Wearable Market

ID: MRFR/AD/56295-HCR

200 Pages

Triveni Bhoyar

Last Updated: April 06, 2026

US Military Wearable Market Size, Share, Industry Trend & Analysis Research Report By Technology (Sensors, GPS Devices, Biometric Monitoring Devices, Augmented Reality), By Type (Smart Helmets, Body Armor, Wearable Exoskeletons, Smart Clothing), By End Use (Army, Navy, Air Force, Special Forces) and By Functionality (Communication, Health Monitoring, Surveillance, Navigation) - Forecast to 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Technology (USD Million)
  1. 4.1.1 Sensors
  2. 4.1.2 GPS Devices
  3. 4.1.3 Biometric Monitoring Devices
  4. 4.1.4 Augmented Reality
2. 4.2 Pharmaceutical, BY Type (USD Million)
  1. 4.2.1 Smart Helmets
  2. 4.2.2 Body Armor
  3. 4.2.3 Wearable Exoskeletons
  4. 4.2.4 Smart Clothing
3. 4.3 Pharmaceutical, BY End Use (USD Million)
  1. 4.3.1 Army
  2. 4.3.2 Navy
  3. 4.3.3 Air Force
  4. 4.3.4 Special Forces
4. 4.4 Pharmaceutical, BY Functionality (USD Million)
  1. 4.4.1 Communication
  2. 4.4.2 Health Monitoring
  3. 4.4.3 Surveillance
  4. 4.4.4 Navigation
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Lockheed Martin (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Northrop Grumman (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Raytheon Technologies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Thales Group (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 BAE Systems (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 General Dynamics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 L3Harris Technologies (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Elbit Systems (IL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Leonardo (IT)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY FUNCTIONALITY
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY FUNCTIONALITY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Technology (USD Million, 2025-2035)

Sensors
GPS Devices
Biometric Monitoring Devices
Augmented Reality

Pharmaceutical By Type (USD Million, 2025-2035)

Smart Helmets
Body Armor
Wearable Exoskeletons
Smart Clothing

Pharmaceutical By End Use (USD Million, 2025-2035)

Army
Navy
Air Force
Special Forces

Pharmaceutical By Functionality (USD Million, 2025-2035)

Communication
Health Monitoring
Surveillance
Navigation

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”